Putrelimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Putrelimab, covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study [Phase 2]